JP2024123940A - ウイルスベクターの製造方法 - Google Patents

ウイルスベクターの製造方法 Download PDF

Info

Publication number
JP2024123940A
JP2024123940A JP2023031784A JP2023031784A JP2024123940A JP 2024123940 A JP2024123940 A JP 2024123940A JP 2023031784 A JP2023031784 A JP 2023031784A JP 2023031784 A JP2023031784 A JP 2023031784A JP 2024123940 A JP2024123940 A JP 2024123940A
Authority
JP
Japan
Prior art keywords
pkc
cells
compound
nucleic acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023031784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024123940A5 (https=
Inventor
彰 垣塚
Akira Kakizuka
雅昭 小池
Masaaki Koike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoto University NUC
Original Assignee
Kyoto University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto University NUC filed Critical Kyoto University NUC
Priority to JP2023031784A priority Critical patent/JP2024123940A/ja
Publication of JP2024123940A publication Critical patent/JP2024123940A/ja
Publication of JP2024123940A5 publication Critical patent/JP2024123940A5/ja
Pending legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2023031784A 2023-03-02 2023-03-02 ウイルスベクターの製造方法 Pending JP2024123940A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023031784A JP2024123940A (ja) 2023-03-02 2023-03-02 ウイルスベクターの製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2023031784A JP2024123940A (ja) 2023-03-02 2023-03-02 ウイルスベクターの製造方法

Publications (2)

Publication Number Publication Date
JP2024123940A true JP2024123940A (ja) 2024-09-12
JP2024123940A5 JP2024123940A5 (https=) 2026-03-24

Family

ID=92676731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023031784A Pending JP2024123940A (ja) 2023-03-02 2023-03-02 ウイルスベクターの製造方法

Country Status (1)

Country Link
JP (1) JP2024123940A (https=)

Similar Documents

Publication Publication Date Title
Chen et al. YY1 regulates skeletal muscle regeneration through controlling metabolic reprogramming of satellite cells
Kraus et al. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter
RS62124B1 (sr) Postupak skrininga jedinjenja za lečenje ili sprečavanje virusne infekcije ili stanja povezanog sa virusom
EP3458579A1 (en) Destabilising domains for conditionally stabilising a protein
Henzi et al. Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice
JP2022103298A (ja) 幹細胞由来移植片からの増殖性細胞の排除
CN107827970B (zh) 一种抑制foxm1的抗肿瘤蛋白肽
Maeda et al. Signal transduction pathways utilized by enzootic nasal tumor virus (ENTV-1) envelope protein in transformation of rat epithelial cells resemble those used by jaagsiekte sheep retrovirus
US9403880B2 (en) Identification of a human gyrovirus and applications
Yao et al. Myosin light chain 3 serves as a receptor for nervous necrosis virus entry into host cells via the macropinocytosis pathway
WO2023033128A1 (ja) タンパク質の製造方法
JP2024123940A (ja) ウイルスベクターの製造方法
Nishio et al. The conserved carboxyl terminus of human parainfluenza virus type 2 V protein plays an important role in virus growth
WO2020260899A1 (en) Screen for inhibitors
JP7668536B2 (ja) 細胞周期のg1期初期制御剤
JP2025523594A (ja) 修飾された融合タンパク質及び核酸コンストラクト
WO2020198320A1 (en) Methods and compositions related to enhancing retroviral vector entry and integration in host cells
Cavaco Understanding the mechanisms at the onset of LAMA2-congenital muscular dystrophy
King Understanding how the Bcl-2 interactome contributes to apoptotic sensitivity
Vinueza Understanding the Role of Delta-Catenin in Virus-Positive Merkel Cell Carcinoma
Bei DDX1 co-amplification confers collateral vulnerabilities in neuroblastoma
WO2025012176A1 (en) Designed ankyrin repeat protein agents targeting brachyury and their use in treatment of chordoma
JP2025139446A (ja) 疾患治療剤のスクリーニング方法,融合遺伝子,及びプロモーター
Burrows Development of a cell based assay for candidate drug screening using transcription factor activated reporter (TFAR) construct
Fang Regulation of paxillin tyrosine phosphorylation and expression byeNOS gene transfection in vascular smooth muscle cells

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260313